---
figid: PMC12108454__antioxidants-14-00605-g002
figtitle: 'New Perspectives on Postmenopausal Osteoporosis: Mechanisms and Potential
  Therapeutic Strategies of Sirtuins and Oxidative Stress'
organisms:
- NA
organisms_ner:
- Homo sapiens
pmcid: PMC12108454
filename: antioxidants-14-00605-g002.jpg
figlink: /pmc/articles/PMC12108454/figure/F2/
number: F2
caption: Normally, SIRT1 activates the Wnt/β-catenin pathway to promote bone formation,
  activates FOXO and PGC-1α to reduce ROS damage to OB, inhibits PPARγ signaling to
  block BMSCs from differentiating to adipocytes, and inhibits the NF-κB signaling
  pathway to reduce OC. SIRT3 activates FOXO, PGC-1α, and SOD2, promotes the AMPK/PGC-1α
  signaling axis, and protects OB, suppresses the NF-κB signaling pathway, and reduces
  OC. SIRT6 activates the Akt-mTOR pathway and ERα-FasL axis and inhibits the NF-κB
  signaling pathway to maintain bone metabolic homeostasis. When estrogen declines,
  the activity of SIRTs decreases and their function is inhibited, leading to the
  exacerbation of PMOP
papertitle: 'New Perspectives on Postmenopausal Osteoporosis: Mechanisms and Potential
  Therapeutic Strategies of Sirtuins and Oxidative Stress'
reftext: Huiying Zhao, et al. Antioxidants (Basel). 2025 May;14(5).
year: '2025'
doi: 10.3390/antiox14050605
journal_title: Antioxidants
journal_nlm_ta: Antioxidants (Basel)
publisher_name: Multidisciplinary Digital Publishing Institute  (MDPI)
keywords: sirtuins | oxidative stress | postmenopausal osteoporosis | natural activator
  | natural antioxidant
automl_pathway: 0.9332061
figid_alias: PMC12108454__F2
figtype: Figure
redirect_from: /figures/PMC12108454__F2
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC12108454__antioxidants-14-00605-g002.html
  '@type': Dataset
  description: Normally, SIRT1 activates the Wnt/β-catenin pathway to promote bone
    formation, activates FOXO and PGC-1α to reduce ROS damage to OB, inhibits PPARγ
    signaling to block BMSCs from differentiating to adipocytes, and inhibits the
    NF-κB signaling pathway to reduce OC. SIRT3 activates FOXO, PGC-1α, and SOD2,
    promotes the AMPK/PGC-1α signaling axis, and protects OB, suppresses the NF-κB
    signaling pathway, and reduces OC. SIRT6 activates the Akt-mTOR pathway and ERα-FasL
    axis and inhibits the NF-κB signaling pathway to maintain bone metabolic homeostasis.
    When estrogen declines, the activity of SIRTs decreases and their function is
    inhibited, leading to the exacerbation of PMOP
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - WNT1
  - WNT2
  - WNT2B
  - WNT3
  - WNT3A
  - WNT4
  - WNT6
  - WNT7A
  - WNT7B
  - WNT8A
  - WNT8B
  - WNT9A
  - WNT9B
  - WNT10A
  - WNT10B
  - WNT11
  - WNT16
  - WNT5A
  - WNT5B
  - FOXO1
  - FOXO3
  - FOXO4
  - FOXO6
  - RUNX2
  - PPARGC1A
  - MID1
  - SP7
  - SOD2
  - SOD2-OT1
  - SIRT6
  - SIRT1
  - PRKAA1
  - PRKAA2
  - PRKAB1
  - PRKAB2
  - PRKAG1
  - PRKAG2
  - PRKAG3
  - APRT
  - MFAP1
  - SIRT3
  - NFKB1
  - TRAP
  - ACP5
  - CD40LG
  - TRAF2
  - TRRAP
  - TDRD7
  - SCYL1
  - CTSK
  - BTF3P11
  - TNFRSF11B
  - TNFRSF11A
  - FASLG
  - TNFSF11
  - NFATC1
  - IL1A
  - IL1B
  - IL6
  - TNF
  - ROS
  - Nucleus
  - OPG
  - TNF-a
---
